These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 14568282)

  • 1. HT and CVD prevention. from myth to reality.
    Wenger NK
    Fertil Steril; 2003 Oct; 80 Suppl 4():10-4; quiz 54-5. PubMed ID: 14568282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menopausal hormone therapy: is there evidence for cardiac protection?
    Wenger NK
    Int Urol Nephrol; 2004; 36(4):617-23. PubMed ID: 15787348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menopausal hormone therapy for cardiovascular protection--unfulfilled expectations.
    Wenger NK
    J Cardiovasc Transl Res; 2009 Sep; 2(3):286-8. PubMed ID: 20560017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
    Harman SM; Naftolin F; Brinton EA; Judelson DR
    Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on menopausal hormone replacement therapy in women and cardiovascular disease.
    Valdiviezo C; Lawson S; Ouyang P
    Curr Opin Endocrinol Diabetes Obes; 2013 Apr; 20(2):148-55. PubMed ID: 23422240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Women's health issues.
    Kaiser FE
    Med Clin North Am; 2003 Sep; 87(5):xi-xiii. PubMed ID: 14621323
    [No Abstract]   [Full Text] [Related]  

  • 8. Postmenopausal hormone therapy and cardiovascular disease in women.
    Stefanick ML
    Nutr Metab Cardiovasc Dis; 2010 Jul; 20(6):451-8. PubMed ID: 20554177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition.
    Naftolin F; Taylor HS; Karas R; Brinton E; Newman I; Clarkson TB; Mendelsohn M; Lobo RA; Judelson DR; Nachtigall LE; Heward CB; Hecht H; Jaff MR; Harman SM;
    Fertil Steril; 2004 Jun; 81(6):1498-501. PubMed ID: 15193467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menopausal hormone treatment cardiovascular disease: another look at an unresolved conundrum.
    Harman SM
    Fertil Steril; 2014 Apr; 101(4):887-97. PubMed ID: 24680648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
    Rosano GM; Vitale C; Fini M
    Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward optimal health: the experts discuss cardiovascular disease. Interviewed by Jodi R. Godfrey.
    Bairey Merz CN; Hayes SN
    J Womens Health (Larchmt); 2005; 14(1):4-10. PubMed ID: 15692270
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prescription of hormonal replacement therapy: a new way to prevent heart diseases].
    Delaye J
    Arch Mal Coeur Vaiss; 1995 Jul; 88(7):951-3. PubMed ID: 7487324
    [No Abstract]   [Full Text] [Related]  

  • 14. Observational studies and clinical trials of menopausal hormone therapy: can they both be right?
    Allison MA; Manson JE
    Menopause; 2006; 13(1):1-3. PubMed ID: 16607089
    [No Abstract]   [Full Text] [Related]  

  • 15. Menopausal hormone therapy: currently no evidence for cardiac protection.
    Wenger NK
    Pediatr Blood Cancer; 2005 Jun; 44(7):625-9. PubMed ID: 15747336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association.
    El Khoudary SR; Aggarwal B; Beckie TM; Hodis HN; Johnson AE; Langer RD; Limacher MC; Manson JE; Stefanick ML; Allison MA;
    Circulation; 2020 Dec; 142(25):e506-e532. PubMed ID: 33251828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?
    Shulman LP
    J Fam Pract; 2004 Jul; Suppl():S13-7. PubMed ID: 15251108
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary prevention of cardiovascular disease with HRT.
    Maclaran K; Stevenson JC
    Womens Health (Lond); 2012 Jan; 8(1):63-74. PubMed ID: 22171776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmenopausal hormone replacement therapy and the prevention of cardiovascular disease: a review.
    Abramson BL
    J Cardiovasc Risk; 2002 Dec; 9(6):309-14. PubMed ID: 12478199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on hormones, menopause, and heart disease: evaluating professional responses to the Women's Health Initiative.
    Derry PS
    Health Care Women Int; 2008 Aug; 29(7):720-37. PubMed ID: 18663631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.